Case 16 A 16-year-old woman with high blood pressure at 32 weeks’ gestation

 Case 16 A 16-year-old woman with high blood

pressure at 32 weeks gestation

Miss Jones is a 16-year-old primigravida who is 32 weeks’

pregnant. At a routine antenatal check with her midwife her

blood pressure is found to be 160/100mmHg (mean arterial

pressure [MAP] 120mmHg).

Her midwife sends her to the maternity day assessment

unit for review.

What differential diagnosis should you

consider?

• Essential hypertension

• Secondary hypertension

• Pregnancy - induced hypertension

• Pre - eclampsia (Box 16.1 ).

What information do you need from

the history?

• Does she have any symptoms that may be related to

high blood pressure? Specifically, headache, visual disturbance, epigastric pain, nausea and vomiting.

• Does she have lots of swelling? Do her rings still fit?

Does she feel her face is swollen?

• Is the baby moving? Has there been any abdominal

pain or vaginal bleeding?

• Has she had any problems with the pregnancy to this

point?

• What was her blood pressure at her booking

appointment?

• Does she have any significant past medical history,

especially renal disease or diabetes?

• Have any of her close family members had high blood

pressure in their pregnancies?

Miss Jones tells you she is feeling absolutely fine, although

she has had to take off her engagement ring and her fiancé

says her face looks puffy. She has been very well in the

pregnancy to this point. There has been no bleeding or

abdominal pain and baby is moving well.

She has no past medical history or family history of note.

She cannot remember her booking blood pressure but you

can see from her notes it was 100/60mmHg.

What are the risk factors for

pre-eclampsia

• First pregnancy, or first pregnancy with new partner

• Multiparous with:

 pre - eclampsia in any previous pregnancy

 10 years or more since last baby

• Pregnancy at extremes of maternal age

• Body mass index (BMI) of 35 or more

• Family history of pre - eclampsia (in mother or sister)

• Booking diastolic blood pressure of 80 mmHg or more

• Booking proteinuria (of one or more, on more than

one occasion or quantified at 0.3 g/24 hours or greater)

• Multiple pregnancy

• Certain underlying medical conditions:

 pre - existing hypertension

 pre - existing renal disease

 pre - existing diabetes

 antiphospholipid antibodies

What features will you look for

on examination?

General examination

• Is she obviously oedematous? Remember 50% of pregnant women will have some peripheral oedema

• What are her pulse and blood pressure now?

Neurological examination

• Does she have normal upper and lower limb reflexes?

• Is there clonus? More than two beats is significant

• On fundoscopy, is there any evidence of papilloedema?

Obstetrics and Gynaecology: Clinical Cases Uncovered.

By M. Cruickshank and A. Shetty. Published 2009 by Blackwell

Publishing. ISBN 978-1-4051-8671-1.110 Part 2: Cases

PART 2: CASES

Abdominal examination

On abdominal palpation:

• Is there tenderness in the right hypochondrium (over

the liver)?

• Does the baby seem well grown?

• Lie and presentation of the baby

• Doppler fetal heart check

Which initial investigation do

you request?

Urinalysis for protein.

Miss Jones looks well. Her BMI is 36 and she has moderate

pitting oedema of her lower legs to mid calf. Her pulse is

86beats/minute and her mean blood pressure over three

readings using an appropriate-sized BP cuff is 155/95mmHg

(MAP 115; Box 16.2). She has normal reflexes and

fundoscopy and no clonus. The baby seems a little small for

gestational age with a symphysiofundal height of 29cm. It

has a longitudinal lie and cephalic presentation, the fetal

heart is heard clearly. Her urinalysis shows ++ protein.

What is the most likely diagnosis based

on the history and examination?

Pre - eclampsia.

Box 16.1 Definitions

Pre-existing hypertension: defined as a systolic blood

pressure of ≥140mmHg, and/or a diastolic blood pressure

of ≥90mmHg, either pre-pregnancy or at booking (before

20 weeks)

Pregnancy-induced hypertension: develops after 20 weeks’

gestation. May reflect a familial disposition to chronic

hypertension or be an early manifestation of pre-eclampsia

Pre-eclampsia: pregnancy-induced hypertension in

association with proteinuria ≥0.3g in 24hours with or

without oedema

Box 16.2 Mean arterial pressure

• The average pressure within an artery over a complete

cycle of one heartbeat:

MAP s = + 1 3 2 3 / / ystolic pressure diastolic pressure

• An MAP of at least 60mmHg is necessary to perfuse

coronary arteries, brain, kidneys, etc.

• Usual range of MAP is 70–110mmHg

What would you do next?

• Admit her to the antenatal ward

• Carry out 4 - hourly BP monitoring

• Fluid intake – output balance chart

• 24 - hour urine collection for quantification of

proteinuria

• Check full blood count (FBC), serum urea and electrolytes (U & E), liver function tests and urate (Box 16.3 )

• Arrange an ultrasound scan for fetal size and well -

being (Box 16.4 ; Figs 16.1 & 16.2 )

• Administer corticosteroids for fetal lung maturity in

case of worsening condition and need for delivery before

36 weeks (Box 16.5 )

Miss Jones consistently has blood pressures below

160/100mmHg so no treatment is required. Her urine

output is good and all blood tests are normal. Ultrasound

confirms that the baby is just above the 5th centile and has

normal liquor volume. A first dose of steroids is given.

Box 16.3 Blood tests in pre-eclampsia

Pre-eclampsia can affect any organ system but some

investigations are especially helpful in suggesting an end

organ effect

Urate

An increase in serum urate levels is often considered the

‘early warning’ blood test in pre-eclampsia and can

indicate renal impairment before U&E becomes deranged

Urea and electrolytes

Indicates renal impairment. Note normal ranges for urea

and creatinine are lower in pregnancy – get reference

ranges from local laboratory

Liver function tests

Become abnormal in variants of pre-eclampsia with liver

involvement especially in HELLP syndrome (haemolytic

anaemia, elevated liver enzymes and low platelet count)

Full blood count

Can indicate HELLP with drop in haemoglobin secondary

to haemolysis and low platelet count

Coagulation screen

Not routinely required but should be included in severe

pre-eclampsia and if platelets are found to be abnormalCase 16 111

PART 2: CASES

x

x x x x x

x

x

x

x

x x

40

38

36

34

32

30

28

26

24

22

20

18

16

14

12

10

8

40

38

36

34

32

30

28

26

24

22

20

18

16

14

12

10

8

20 22 24 26 28 30 32 34 36 38 40

20 22 24 26 28 30 32 34 36 38 40

Gestational age (weeks)

Circumference (cm)

Circumference (cm)

Gestational age (weeks)

Estimated date of delivery

Abdominal circumference

Head circumference

Figure 16.1 Example of fetal growth chart.

Normal flow Reduced end diastolic flow

Absent end diastolic flow Reversed end diastolic flow

Figure 16.2 Umbilical artery Doppler waveforms.

Figure 16.3 Normal umbilical artery Doppler.112 Part 2: Cases

PART 2: CASES

Box 16.4 Intrauterine growth restriction

In pre-eclampsia, a combination of abnormal placentation

and hypertension can result in reduced placental blood

flow and fetal nutrition leading to intrauterine growth

restriction (IUGR). IUGR is a term used to describe a baby

that is smaller than expected for gestation; the usual

cut-off is <5th centile for gestation. In addition to

pre-eclampsia there are a variety of other problems that

can result in IUGR.

Maternal factors

• High blood pressure

• Chronic kidney disease

• Advanced diabetes

• Heart or respiratory disease

• Malnutrition, anaemia

• Infection

• Substance abuse (alcohol, drugs)

• Cigarette smoking

Factors involving the uterus and placenta

• Decreased blood flow in the uterus and placenta

• Placental abruption (placenta detaches from the

uterus)

• Placenta previa (placenta attaches low in the uterus)

• Infection in the tissues around the fetus

Factors related to the developing fetus

• Multiple gestation (twins, triplets, etc.)

• Infection

• Birth defects

• Chromosomal abnormality

It is important to identify these fetuses as babies with

IUGR are at an increased risk of problems at birth

including:

• Hypoxia/hypoxaemia

• Low Apgar scores

• Meconium aspiration

• Hypoglycaemia

• Hypothermia

• Polycythaemia

In addition, severe IUGR may result in stillbirth. It may

also lead to long-term growth problems in babies and

children.

If a fetus is found to be <5th centile for gestation, further

ultrasound assessment including liquor volume, umbilical

artery Doppler studies (umbilical arterial blood flow becomes

abnormal when there is placental insufficiency) and

biophysical profiles can help to distinguish those babies who

are small but coping, from those babies who are struggling

and will benefit from early delivery despite being premature

(Figs 16.2 and 16.3).

Box 16.5 Drug choices for high blood pressure

It remains unclear whether antihypertensive drug therapy

for mild to moderate hypertension during pregnancy is

worthwhile. Antihypertensive treatment should be

started in women with a systolic blood pressure

>160mmHg or a diastolic blood pressure >110mmHg;

MAP 125mmHg.

In women with other markers of potentially severe

disease, treatment can be considered at lower degrees of

hypertension.

Labetalol (orally or intravenously), oral nifedipine or

intravenous hydralazine can be used for the acute

management of severe hypertension. Both labetolol and

hydralazine can be given as IV boluses with or with out

infusions.

ACE inhibitors, angiotensin receptor-blockers and

diuretics should be avoided.

What will you tell Miss Jones about

her condition?

She has a condition called pre - eclampsia. This is a combination of high blood pressure and protein in the urine.

It is important because it can affect both the mother ’ s

and the baby ’ s health. About 25% of women will get high

blood pressure in their first pregnancy and 5/1000

women will develop severe pre - eclampsia. The only

‘ cure ’ for the condition is delivery of the baby and

placenta.

However, as the baby is preterm and she is feeling well,

as long as her blood pressure is satisfactory, all her blood

tests are normal and baby is coping well (normal scans

and cardiotocography [CTG]) the plan is to wait and

monitor her and the baby until it is mature (≥37 weeks).

At 02.00 the next night Miss Jones calls the midwife to say

she has a mild headache and could she have some

paracetamol. The midwife checks her blood pressure and

finds it to be 170/110mmHg (MAP 130). She calls the doctor.Case 16 113

PART 2: CASES

What will you do?

Attend as soon as possible. One per cent of women with

severe pre - eclampsia will develop an eclamptic seizure

which has a mortality rate of 1.8%, with 35% suffering

severe morbidity.

Site IV access, check bloods as above plus urgent group

and save and coagulation screen in case delivery is

necessary.

Inform your senior and arrange transfer as soon as

possible to a high dependency area (usually the labour

ward).

Miss Jones’ headache is now severe with a pain score of

9/10. She has no visual disturbance or epigastric pain but is

hyper-reflexic and has marked clonus. Her blood pressure

remains 170/110mmHg (MAP 130) and she now has ++++

protein in her urine.

What are your priorities?

• Reduce her blood pressure

• Seizure prophylaxis (Box 16.6 )

• Recheck blood pressure, re - examine and site catheter

for urinalysis and hourly urine volumes

• Maintain strict fluid balance restricted to 80 mL/hour

(Box 16.7 )

Once the mother is stabilized perform CTG and

arrange urgent delivery (Box 16.8 ).

Box 16.6 Seizure prophylaxis

Magnesium sulphate should be considered when there is

concern about the risk of eclampsia. In women with less

severe disease, the decision is less clear and will depend

on the individual case.

Magnesium sulphate is the therapy of choice to control

seizures. A loading dose of 4g is given by infusion pump

over 5–10minutes, followed by a further infusion of 1g/

hour maintained for 24hours after the last seizure.

Recurrent seizures should be treated with either a

further bolus of 2g magnesium sulphate or an increase in

the infusion rate to 1.5g or 2.0g/hour.

During administration it can cause flushing and

palpitations and cause the woman to feel quite unwell so

it is important to warn her about this before commencing

the treatment.

Box 16.7 Fluid balance

Fluid restriction is advisable to reduce the risk of fluid

overload in the intrapartum and postpartum periods. Total

fluids should usually be limited to 80mL/hour or 1ml/kg/

hour.

Urine volumes of ≥0.5mL/kg/hour are desirable. Usually,

30mL/hour is acceptable.

Oliguria is common initially but if persistent its

management should involve senior anaesthetic and

obstetric staff and invasive monitoring of central venous

pressure because of a significant risk of fluid overload and

problems with pulmonary and cerebral oedema.

Box 16.8 Choice of mode of delivery

The decision to deliver should be made once the woman is

stable and with appropriate senior personnel present.

If the fetus is less than 34 weeks’ gestation and delivery

can be deferred, corticosteroids should be given, although

after 24hours the benefits of conservative management

should be reassessed. Conservative management at very

early gestations may improve the perinatal outcome but

must be carefully balanced with maternal well-being.

The mode of delivery should be determined after

considering the presentation of the fetus and the fetal

condition, together with the likelihood of success of

induction of labour after assessment of the cervix.

The third stage should be managed with 5units

Syntocinon IM or slow IV. Ergometrine and Syntometrine

should not be given for prevention of haemorrhage, as

this can further increase the blood pressure.

KEY POINT

Magnesium toxicity is important as it can ultimately cause

respiratory and cardiac depression and death. One of the

earliest signs of toxicity is loss of deep tendon reflexes,

and patellar tendon reflexes (or bicep tendon in the case

of a woman with epidural or spinal anaesthetic) should be

performed hourly during treatment.

Respiratory rate should also be monitored and, as

magnesium is excreted in urine, if hourly urine volumes fall

considerably it is sensible to halve the rate of infusion.

Magnesium levels are not routinely monitored but if there

was any clinical concern regarding toxicity stopping the

infusion and taking a serum level may help with

decision-making.

The antidote is calcium gluconate and this should be

used immediately in cases of respiratory or cardiac

depression.114 Part 2: Cases

PART 2: CASES

Miss Jones’ blood pressure improves following 5mg

hydralazine IV to 145/90mmHg. Her headache resolves with

this treatment. She is commenced on magnesium sulphate

for seizure prophylaxis. The CTG is satisfactory. Her cervix is

unfavourable for induction of labour (Bishop score 3; see

Case 1) and as her platelets and coagulation are normal a

decision is made for emergency caesarean section.

An uncomplicated section is performed and a healthy

male baby is delivered. As 44% of eclamptic seizures occur

postnatally it is vital to remain vigilant so Miss Jones is

transferred back to the high dependency unit.

What will be your plan for

postnatal care?

Intensive monitoring of pulse, blood pressure and oxygen

saturation every 15 minutes initially, reducing to hourly

once she is completely stable. Also take hourly urine

volume measurements. Administer magnesium sulphate

for 24 hours following delivery and take hourly reflexes

while she is on magnesium sulphate. Repeat blood tests

at least daily until she is well. Use thromboembolic

disease (TED) stockings and low molecular weight

heparin for deep venous thrombosis prophylaxis if coagulation and/or platelet count is normal.

Miss Jones improves significantly over her first 24hours

postnatally. Her blood pressure remains stable and daily

blood tests are normal. She is observed for a further 4 days

on the postnatal ward before discharge. On day 2 her blood

pressure is noted to be slightly elevated, she is commenced

on oral antihypertensive therapy and her blood pressure

improves. Her baby is doing well in the neonatal unit. She

asks the midwife if she will always need tablets for her

blood pressure now and if she will develop pre-eclampsia in

her next pregnancy. The midwife calls you to talk to her

before discharge.

What will you tell her?

Most women who develop pre - eclampsia become completely better over a period of days to weeks but some

women will require treatment for longer. Her GP will

check her blood pressure regularly and stop her tablets

when she no longer needs them. If her blood pressure is

high at 6 weeks they will refer her for investigation of this.

More women who have pre - eclampsia will develop

high blood pressure in later life compared with the whole

female population. Women who have pre - eclampsia in a

first pregnancy are at an increased risk (7 – 10%) of developing it in a subsequent pregnancy.

Miss Jones is happy with your explanation and is discharged

to the care of her GP. An appointment for a postnatal check

is made with her consultant for 6 weeks’ time in view of her

severe pre-eclampsia.

CASE REVIEW

Miss Jones, in view of her age of 16 years and being in her

first pregnancy, had risk factors for developing pre -

eclampsia. As in most cases, pre - eclampsia was first picked

up on routine antenatal screening with BP and urine

protein checks which are performed at every antenatal

visit. She demonstrated some of the complications of pre -

eclampsia including a small baby and signs of impending

eclampsia with a significant increase in her blood pressure.

Prophylaxis for eclampsia was with magnesium sulphate

and the blood pressure was controlled rapidly with hydralazine IV. The only treatment for pre - eclampsia is delivery

of the baby and once maternal condition was stabilized

delivery was planned. As her cervix was unfavourable with

a low Bishop ’ s score, an emergency caesarean section was

performed. Her monitoring continued postpartum as the

risks of severe pre - eclampsia remain for some time

postnatally.

Pre - eclampsia is a common and serious complication of

pregnancy. There are specific factors that put women at

increased risk of pre - eclampsia but it can occur in anyone.

Severe pre - eclampsia can affect any maternal organ system

and can cause fetal intrauterine growth restriction (IUGR)

and placental abruption.

Five in 1000 women will develop severe pre - eclampsia

and 5 in 10,000 will have an eclamptic seizure. Of these,

38% of seizures occur antenatally, 18% intrapartum and

44% postnatally.

Low dose aspirin prophylaxis may be beneficial in preventing recurrence of pre - eclampsia when there has been

early onset of severe disease with or without IUGR.

Appropriate management of blood pressure can sometimes prolong pregnancy but the only cure for pre - eclampsia is delivery of baby and sometimes this will have to be

at an early gestation despite the risks to the fetus.Case 16 115

PART 2: CASES

KEY POINTS

• Extremes of maternal age, first pregnancy (or first

pregnancy with a new partner) and multiple pregnancy

are some of the risk factors for pre-eclampsia

• Maternal complications of pre-eclampsia include HELLP,

renal failure, disseminated intravascular coagulopathy,

pulmonary odema, intracerebral haemorrhage and

eclampsia. Over 40% of eclamptic fits occur postpartum

• Fetal complications include IUGR, increased perinatal and

neonatal morbidity and mortality, mostly due to IUGR and

prematurity (which is very likely to be iatrogenic)

• Headaches, visual disturbances, epigastric and/or right

hypochondrial tenderness and hyper-reflexia suggest

worsening of pre-eclampsia and/or impending eclampsia.

Magnesium sulphate is the treatment of choice for

eclampsia and prophylaxis of eclampsia

• Antihypertensives are indicated with MAP readings of 125

or above (or with systolic readings ≥160mmHg and

diastole ≥110mmHg)

• Close monitoring of blood pressure, fluid intake and

output, and blood investigations (including haemoglobin

and platelet counts, U&E, liver function tests) is indicated

with severe pre-eclampsia

• In the presence of oliguria, central venous pressure

monitoring should be considered before fluid challenges

to avoid the risks of fluid overload and pulmonary and

cerebral odema

Further reading

The management of severe pre - eclampsia/eclampsia. RCOG

Green topped Guideline No 10 (A), March 2006.

Nhận xét